Daily MaverickECOSYSTEM THREAT: Gill nets galore in Kosi lakes, despite illegal fishing clampdownESPNA Cubs-White Sox World Series? Why this could be the best chance since 1906וואלהשני מחבלים שקידמו מתווי טרור נעצרו בכפר קבאטיהESPN Deportes¿Quién es Joshua Báez? El dominicano del histórico debut de 3 jonronesThe Jerusalem PostHealth Min. reviews possible sperm donor genetic mismatch at Assuta Medical Center, Tel AvivVarietyDonald Trump Attacks CNN’s Kristen Holmes for Asking If He Spoke to North Korean Dictator: ‘You’re a Loud, Boisterous Person. Be Quiet!’Global NewsAlberta government misses treaty anniversary eventSBS 뉴스'친청계 3인' 전원 최고위원 입성…김용은 탈락BBC NewsJason Arday's family 'still coming to terms' with his death as vigil heldDeadlineNew Yorker’s Ariel Levy To Join ’60 Minutes’ As A ContributorSRF NewsQ&A Besser konzentrieren – «Was kann bei ADHS die Konzentration verbessern?»Digital SpyCelebrity Hunted viewers spot suspicious coincidence during narrow escape plan
The Daily Newsstand · Free, Always
Monday, August 17, 2026

Legarda extends medical leave anew

Translate

MANILA, Philippines — Sen. Loren Legarda has asked for another extension of her medical leave abroad amid an ombudsman investigation on her and her son for allegedly anomalous solar projects.

Senate Secretary Renato Bantug Jr. confirmed that Legarda has extended her medical leave again from Aug 17 to 19.

“Yes. Her office sent in a letter this morning. Medical leave from 17 to 19 August,” Bantug said.

Legarda has been on leave, missing out on her senator-judge duties, since Ombudsman Jesus Crispin Remulla announced two weeks ago that a preliminary investigation is ongoing on her, son Batangas Rep. Leandro Leviste and former energy secretary Alfonso Cusi for plunder and graft.

Remulla accused Legarda of using her post to secure exclusive solar power franchises for Leviste that allegedly resulted in multibillion-peso “ghost electricity” losses.

View the original on The Philippine Star

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.